MedPath
HSA Product

PROCODIN SYRUP

Product approved by Health Sciences Authority (SG)

Basic Information

PROCODIN SYRUP

SYRUP

Regulatory Information

SIN04075P

March 28, 1990

Pharmacy Only

Therapeutic

ORAL

August 10, 2023

June 3, 2025

XR05DA20

Company Information

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Active Ingredients

CODEINE PHOSPHATE

Strength: 9 mg/5 ml

PROMETHAZINE HCl

Strength: 3.6 mg/5 ml

© Copyright 2025. All Rights Reserved by MedPath